Next-generation Cancer Diagnostics Market Explores New Growth Opportunities By 2024

The cancer diagnostics industry is projected to witness lucrative growth in the next few years due to the increasing number of technologically advanced products providing accurate test results in the field of diagnostics. Additionally, they also help with therapeutic monitoring and early diagnosis of cancer. Significant improvements observed in the shift from traditional laboratory testing to rapid point of care testing (POC) drive this market. Commercialization of products such as diagnostic kits, instruments, reagents, and consumables plays a role as well. The decreasing cost of genetic sequencing, rising incidence of cancer, increasing interest in the microfluidic hip technology, and the use of circulating tumor cells (CTCs) in cancer management have also aided the development of the next-generation cancer diagnostics market.

Read the Comprehensive Overview of Next-generation Cancer Diagnostics Market: http://www.transparencymarketresearch.com/next-generation-cancer-diagnostics-market.html

Government measures taken by developed and developing countries to increase the number of research projects in accordance with oncology and preventative diagnosis are anticipated to propel the next-generation cancer diagnostics market over the next few years. The application of tumor diagnostics in the epigenetic analysis and CTC enumeration sectors to monitor tumorigenesis is predicted to make a difference as well. However, the market may be limited by the high laboratory infrastructure costs involved. Insufficient reimbursement policies for innovative technologies and the stringent regulatory procedures and guidelines followed by the government are other factors affecting the global next-generation cancer diagnostics market.

This market is segmented by technology into the following categories: qPCR & multiplexing, protein microarrays, next-generation sequencing (NSG), DNA microarrays, lab-on-a-chip, and reverse transcriptase-PCR (RT-PCR), of which microarrays and PCR are expected to dominate the market due to their rising usage in invitro diagnostics by hospitals and private diagnostics clinics.

Based on application, the next-generation cancer diagnostics market is classified into the following groups: genetic analysis, biomarker development, epigenetic analysis, and CTC analysis & proteomic analysis, of which biomarkers and CTC analysis are likely to drive the market as these techniques are widely used in drug discovery and development.

The market, in terms of cancer type, is divided into the cervical, breast, colorectal, lung, and other varieties. Its function-based divisions are cancer screening, companion diagnostics, therapeutic monitoring, prognostics, and risk analysis, of which diagnostics and therapeutic monitoring are projected to be the leading segments.

Geographically the next-generation cancer diagnostics market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the market due to favorable government initiatives (such as the “80% by 2018” movement for colon cancer detection), healthy R&D investments, personalized medicine, development of next-generation sequencing, and availability of a technologically advanced health care research framework. The market in Asia Pacific is projected to register a prominent growth rate owing to the development of health care infrastructure, significantly large untapped market base, and economic development in the region.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19568

Prominent players in the next-generation cancer diagnostics market include Thermo Fisher Scientific, Inc; Opko Health, Inc;  Myriad Genetics, Inc.; Agilent Technologies; GE Healthcare Cepheid; Koninklijke Philips N.V; F. Hoffmann-La Roche Ltd; Qiagen; Novartis AG; Abbott; PerkinElmer, Inc.; Genomic Health, Inc.; Illumina, Inc; and Sysmex Corporation.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Far Infrared Therapy Device Market Future Trends And Industry Analysis Upto 2024

Far infrared light is measured in microns and can be divided into far-infrared, mid-infrared, and near-infrared. The far-infrared light is a part of an invisible spectrum of the sun. The near-infrared ranges from 0.7 to 2.0 microns, mid-infrared ranges from 2 to 4 microns, and far-infrared ranges from 4 to 1,000 microns. The vibrant range for the best benefit is considered from 8.4 to 9.4 microns. The detectible red and far infrared portions of the spectrum that range from 660 to 880 wavelength are consider the vital range, as they are highly absorbent and create unique restorative effects on living tissues.

Obtain the Report Details for Far Infrared Therapy Device Market: http://www.transparencymarketresearch.com/far-infrared-therapy-device-market.html

It is studied that the skin and underlying tissues absorb the light photons, which activate changes such as photobiomodulation in a body. Photobiomodulation is a light-induced photochemical reaction. Far infrared rays are anti-bacterial, anti-fungal, and anti-viral and, therefore, can be beneficial in the treatment of a range of diseases. Far infrared waves are thermal, and in the electromagnetic spectrum, they are closer to the microwave region which we experience as heat. There are many benefits of natural sunlight delivered by far infrared heat without the dangerous effects of UV radiation. The thermal radiation is a prime source of infrared radiation, i.e., any object which has a temperature radiates in the infrared. It emits more infrared radiation as it gets warmer. Even cold objects such as an ice cube are likely to emit some evident infrared. The far infrared therapy devices use the deep penetrating light (DPL) systems are popular. Various physical conditions can be treated with DPL system. The system uses energy in the form of photons to penetrate deep into the skin. The far infrared light can penetrate up to 30 to 40 mm in the skin, which makes it more effective and preferable for joints, deep muscles, and bones.

The global FAR infrared includes variety of devices applicable for several indications such as FAR infrared heating pads, FAR infrared sauna, FAR infrared heater, FAR infrared sauna with carbon heater, FAR infrared gloves, FAR infrared lamp, and other light therapy devices. The FAR infrared therapy devices are used in a number of therapies such as pain relief, skin rejuvenation, and relief from sports injuries, toxin elimination, stress reduction, weight loss, restful sleep, and improving immune system. The rays help in heating muscles, nerves, blood vessels, joints, and bones. Conditions such as arteriovenous fistula (which causes blood to directly flow from an artery into a vein) can be treated by FAR infrared therapy devices. From widely used applications of FAR infrared devices for treating various medical conditions, the heating therapy is the most commonly used all over the world. The heating therapy is used to detoxify heavy metals, reduce cholesterol, and promote blood circulation. The ease of use, effectiveness, and safe and wide applicability of the FAR infrared therapy device are likely to drive the market in the near future. However, the threat of side effects, such as sunburn, may act as a restrain for the market.

Based on geography, the FAR infrared devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market. Rise in geriatric population and high per capita income are projected to propel the market in this region. Further, increase in adoption of personalized health technologies is one of the key factors which is likely to drive the market during the forecast period. North America is followed by Europe, and the region holds a large share of the market. Asia Pacific is the most progressive region. The increase in health care awareness and rise in per capita income are estimated to drive the market in Asia Pacific.

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19556

The global players operating in the FAR infrared therapy device market are Medtronic plc, Omron Corporation, Panasonic Corporation, and Siemens AG. Along with the global players, the regional players are contributing a significant share in the FAR infrared device market.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Minimally Invasive Surgeries will Bolster the Growth of Spine Implant Market

Global Spine Implant Market: Overview

The current development of bio-resorbable implants that automatically leave the body as the patient recovers is projected to speed up the expansion of the spine implant market. Spinal implants are used to correct deformities, strengthen the spine, and facilitate fusion. Some of the major conditions that require spine implants are chronic degenerative disc disease, spondylolisthesis, scoliosis, traumatic fracture, and other forms of spinal instabilities.

Obtain the Report Details for Spine Implant Market: http://www.transparencymarketresearch.com/spine-implant-market.html

The report carries out an in-depth analysis of the major drivers, restraints, trends, opportunities, and segments of the global spine implant market. The key factors of the global spine implant market such as value chain analysis, competitive landscape, Porter’s five force analysis, market attractiveness, market forecast, and supply and demand ratio have been thoroughly dealt with in the report. The report also sheds light on the market shares held by the leading firms, in addition to a description of their product portfolios and major business strategies.

Global Spine Implant Market: Drivers and Restraints

The key factors aiding the growth of the global market for spine implants are the rise in the number of spinal injuries and disorders and technological advancements in the field of spine implants.  Minimally invasive surgeries have been witnessing high demand due to quicker recovery and lesser discomfort. This will prove to be another key growth driver of the market.

The number of geriatric and obese population has been escalating, providing significant growth opportunities to the market. The increasing prevalence of postural defects, lack of physical exercise, and high incidence of obesity are increasingly affecting the spinal cord, leading to numerous spinal problems. Therefore, the global market for spine implants will witness an upsurge, growing with a steady CAGR during the forecast period.

On the contrary, factors such as tedious approval procedures, high costs of treatments, absence of awareness about these procedures among patients and physicians, and uncertain reimbursements are some of the chief challenges faced by the global spine implant market. However, the introduction of image-based spinal navigation technology, along with the advancements in the field of titanium biologics will present considerable opportunities.

Global Spine Implant Market: Regional Outlook

The global market for spine implants can be segmented to include North America, Asia Pacific, Middle East and Africa, Latin America, and Europe. North America is likely to be the leading regional segment, accounting for the largest share in the overall market. The prominence of this region can be attributed to technological developments, government funds, extensive R&D activities, and the rise of innovative treatment procedures. The U.S. will be at the headmost position in this region.

Asia Pacific is a budding market with great potential owing to the presence of a large patient population, widespread adoption of sedentary lifestyles, increased healthcare expenditure, rising awareness about the availability of spine implants, beneficial government policies, and rising per capita incomes of people. Although the spine implant markets in India and China are growing at a rapid rate, Japan is expected to emerge with lucrative opportunities on account of its highly skilled surgeons, attractive market economics, and established regulatory systems.

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19433

Companies Mentioned in the Report

Some of the major companies operating in the global market for spine implants are Aesculap Implant Systems, Ulrich Medicals, Titan Spine, Stryker, Medtronic, Zimmer Biomet Corporation, and DePuy Synthes.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Short Bowel Syndrome Market to Rise at a CAGR of 30.4% to Reach a Valuation of US$2.6 Bn by 2024

Global Short Bowel Syndrome Market: Overview

Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition. In certain instances, a major part of the large intestine is removed through surgeries that might result in SBS in the patients. The major causes of SBS in infants include necrotizing enterocolitis, intestinal atresia, gastroschisis, and malrotation with volvulus, among others. In adults, SBS is observed in Crohn’s disease, radiation enteritis, and mesenteric ischemia, among others. The medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal (to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence parenteral nutrition is the preferred mode of treatment in these patients.

Obtain the Report Details for Short Bowel Syndrome Market: http://www.transparencymarketresearch.com/short-bowel-syndrome-market.html

Global Short Bowel Syndrome Market: Research Methodologies

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of drugs employed in the treatment of short bowel syndrome in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for drug class, and geography for the period 2014 to 2024, considering the macro and micro environmental factors. The revenue generated from each drug class was calculated by considering prevalence rate of short bowel syndrome, the cost of the drugs, reimbursement scenario, drug availability, patent expiries, and adoption rate of the drugs, across all the geographies.

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on drug class, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the short bowel syndrome market in the current and future scenario. The report also provides value chain analysis of the market that describes the sequence of activities involved, from identification of the market need to their final reach to the end users.

Global Short Bowel Syndrome Market: Scope of the Study

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, and Rest of the World. The study also covers detailed country analysis contributing majorly in the short bowel syndrome market.

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13346

Key Players Mentioned in this Report are:

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the short bowel syndrome market report are Ardelyx, Inc., Emmaus Life Sciences, Inc., GLyPharma Therapeutic, Inc., Merck KGaA, Naia Pharmaceuticals, Inc., Nutrinia Ltd., OxThera, Sancilio & Company, Inc., Shire plc, and Zealand Pharma A/S, among others.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Aggressive Spread of Peripheral Vascular Disorders Upwells Demand for Lab on Chips Market

The lab on chips technology comes handy as it allows to perform several experiments on the small chips with a solid platform. In many ways they act as mini laboratories, which is the chief driver of their demand across the healthcare sector. The microfluidic technique was developed back in 1990s and have been exhibiting growth at a steady pace since its advent. The global lab on chips market is forecast to grow at a rapid pace on account of its increasing application in healthcare and drug development techniques. The implementation of the technology has resulted in the development of various point of care devices and in-vitro diagnostic techniques such as pregnancy kits and glucometer kits. Due to their increasing application in in-vitro diagnostics, drug discovery, and other pharmaceutical operations, the acceptance of lab on chip techniques has significantly increased.

Obtain the Report Details for Lab on Chips Market: http://www.transparencymarketresearch.com/lab-on-chips-market.html

Transparency Market Research (TMR) has projected the global lab on chips market to exhibit a CAGR of 10.7% between 2016 and 2024. At this pace the market is expected to reach US$8.7 bn by the end of 2024 from a valuation of US$3.88 bn in 2016.

Regionally, North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa constitute the key market segments. Among these, the year 2016 saw North America emerging as the leading segment, trailed closely by Europe. Despite the early adopter advantage of North America, the market is expected to witness riper opportunities in Asia Pacific. TMR forecasts the lab on chips market in Asia Pacific to register an impressive 12.3% CAGR during the forecast period.

Gaining impetus from the rising population and the latest technological advancements, Asia Pacific will continue exhibiting attractive opportunities. Also because microfluidic techniques offer more advantages over the counterparts, expanding industries across Asia Pacific are more likely to invest in them. For instance, the advent of Point-of-care (POC) devices and in-vitro diagnostic (IVD) technology, has enabled vendors to manufacture superior microfluidic chips and products. On account of the rising awareness about how diverse industries can benefit from integrating these advancements, the demand for lab on chips is forecast to rise in Asia Pacific.

In terms of product, the global lab on chips market can be classified into reagents, instruments, and consumables. Of these, instruments emerged dominant in the global lab chips market in terms of revenue. In 2016 the segment held over 45% of the market on account of the high acceptance of microfluidic products in industries and labs. Besides this, growth witnessed in the reagents and consumables segments is prophesized to rise at a favorable pace.

Activities undertaken towards miniaturization of bio analytical techniques offer advantages such as compact design for equipment, less expensive, and enable analogous operations for multiple analyses. Driven by the factor, the demand for lab on chips products is expected to rise in the coming years. Additionally, microfluidics help in converting top laboratory protocols into a single chip. This not only facilitates diagnostics but has made home healthcare more convenient than ever. Such technological advancements are forecast to keep the demand for various lab on chips techniques high, thereby benefiting the various product categories.

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20261

Some of the leading players operating in the global lab on chips market are Danaher Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc, Thermo Fisher Scientific, Inc, RainDance Technologies, Inc., and F. Hoffmann La-Roche Ltd.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Widening Base of Obese and Aged People to Trigger Adoption for Hip Replacement Implant Market

Global Hip Replacement Implant Market: Snapshot

Hip replacement implants are used for replacing damaged hip to restore bodily function to as normal as possible. Damage caused to the hip due to injuries, disease, or fractures can be corrected with hip replacement implants. The demand for hip replacement implants has been on the rise in recent years due to the growing number of injuries and the subsequent demand for surgeries for the required correction. Owing to this reason, the global market is expected to be worth US$9.1 bn by the end of 2024 as compared to US$6.5 bn in 2015. Between the forecast period of 2016 and 2024, the global market is estimated to expand at a CAGR of 3.9%.

Obtain the Report Details for Hip Replacement Implant Market: http://www.transparencymarketresearch.com/hip-replacement-implants-market.html

High Prevalence of Trauma to Hips Augments Demand in Global Market

The steady growth of the hip replacement implant market is attributed to rising geriatric population, increasing incidences of accidents, and rising prevalence of osteoarthritis. Technological advancements in the field of artificial hip implant resulting in new and innovative products such as mobile bearing hip implant and various material combination implants have increased the mobility and flexibility of the leg. These innovations have also reduced the side effects for artificial implants, thereby augmenting their demand.

Total Hip Replacement Implant Segment to Lead Global Market throughout Forecast Period

On the basis of product, the global market is segmented into total hip replacement implant, hip resurfacing implant, partial hip replacement implant, and revision hip replacement implant. The total hip replacement implant segment is further fragmented into fixed bearing hip implants and mobile-bearing total hip implants. Of all these segments, the total hip replacement implant segment held a leading share in the global market. The report indicates that this segment will continue to lead against the backdrop of growing incidences of trauma to the hips and increasing prevalence of osteoarthritis amongst the elderly.

North America Poised to Dominate as Region Witnesses Rising Healthcare Expenditure

In terms of geography, the global market is segmented into Europe, North America, Asia Pacific, the Middle East and Africa, and Latin America. Of these, North America dominated the global market in 2015 and is expected to continue its dominance during the forecast period. This is due to high prevalence of osteoarthritis, increasing health care expenditure leading to increase in demand for better medical devices and health care services, and number of technological advancements in the field of hip replacement implants. However, the market in Asia Pacific is projected to register a significant growth rate by 2024 due to availability of large patient pool and increasing awareness about health. In addition, high percentage of geriatric population, and increasing disposable income are expected to offer opportunities.

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1901

The key players operating in the global hip replacement market are B. Braun Melsungen AG, Exactech, Inc., DJO Global, Inc., Johnson & Johnson, MicroPort Scientific Corporation, OMNIlife science, Inc., Smith & Nephew, Zimmer Biomet Holdings, Inc., and Stryker Corporation. As of 2015, Zimmer Biomet Holdings, Inc. held a leading share in the global market with its winning business strategies such as acquisition of Clinical Graphics. The company is anticipated to continue its stance in the global market throughout the forecast period as it is expected to make significant investments in research and development of new products.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Rise in Geriatric Population Prone to Brain Disorders Augments Demand for EEG-EMG Equipment Market

Global EEG and EMG Equipment Market: Snapshot

Electroencephalography (EEG) and electromyography (EMG) are neurophysiology devices that are designed to help physicians assess the functions of the central and peripheral nervous system such as the muscular system. These analytical tools are used for understanding the progression of diseases and disorders such as epilepsy, sleep disorders, neurological critical care, and cognitive alterations. Therefore, the rising pool of geriatric population that is prone to these conditions is expected to drive the growth of the global EEG-EMG equipment market in the coming years. Owing to these reasons, the global market is expected to be worth US$2.4 bn by the end of 2024 from US$1.3 bn in 2015. Between the forecast period of 2016 and 2024, the global market is estimated to expand at a CAGR of 7.4%.

Obtain the Report Details for EEG-EMG Equipment Market: http://www.transparencymarketresearch.com/eeg-emg-equipment-market.html

The market is also likely to be driven by the high prevalence of brain disorders among elderly population such as Alzheimer’s disease and Parkinson’s disease. Furthermore, remarkable innovations in the technologies used in the overall market for developing devices to treat sleep disorders are expected to accelerate the growth of the global EEG-EMG equipment market. The increasing number of pediatric neurological disorder cases are also expected to augment the demand for EEG-EMG equipment in the near future. The commonly seen pediatric neurological disorders are brain tumors, spinal degenerative diseases, neuropathies, movement disorders, and epilepsy.

Electroencephalography to Lead the Pack as their Adoption in Hospitals and Research Institutes Increases

On the basis of product, the global EEG-EMG equipment market is divided into electroencephalography and electromyography. Of these, the EEG segment led the pack, accounting for nearly 61.6% share in the global market in 2015. This segment is expected to continue its dominance throughout the forecast period as they are used in neurodiagnostic centers, hospitals, and research institutes in order to gain accurate and effective diagnostic results.

The report also indicates that the EMG segment is also anticipated to grow at a phenomenal pace during the forecast period as the cases of spinal cord or neural diseases among geriatric population continue to be on the rise. The innovation in technologies and software to enhance the quality of EEG equipment required for treating Alzheimer’s disease and Parkinson’s disease are also projected to drive the global market.

North America Emerges as Key Regional Market with Robust Healthcare Programs

In terms of geography, the global EEG-EMG equipment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held a leading position in the global EEG-EMG equipment market in 2015, accounting for a share of 35.1% in the overall market. The region is expected to continue its dominance in the coming few years due to the high prevalence of neural diseases and presence of healthcare awareness program for the aging population. Additionally, technological developments and growing demand for neurophysiology devices from both physicians and researchers are also anticipated to impact the regional market in a positive way.

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2872

The key players operating in the global EEG-EMG equipment market are Nihon Kohden Corporation, Cadwell Industries, Inc., Compumedics Limited, Medtronic, Natus Medical Incorporated, Electrical Geodesics Inc., Masimo Corporation, Zynex Inc., Allengers Medical Systems Limited and others. As of 2016, Nihon Kohden Corporation held a dominant share in the global EEG-EMG equipment market.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Increasing Demand for Better Prescription Lens Products Drives Lens Blocker Systems Market

Lens blocker systems are instruments used by optometrists and ophthalmologists across the world to manufacture eye glass lenses or prescription lenses. The lens blocker systems perform the major function of detecting the optical center of the eye glass lenses, and other important functions such as shape, power, and other features of the lenses. These are then mounted in the wearable frames. A prescription lens is made of glass or plastic. It is inserted into frames to correct vision problems faced by people. The manufacturing process of these prescription lenses includes three major steps: blocking, polishing, and beveling. In the blocking stage, the blank glass or plastic lenses are mounted on the blocker systems, which locates and marks the optical center of the blank lens, in order to create a perfectly shaped lens suitable for the wearer. Blocking of the lenses is the most important process in order to manufacture a perfectly shaped optical lens, with desired power and other features.

Read More Information Regarding Lens Blocker Systems Market: http://www.transparencymarketresearch.com/lens-blocker-systems-market.html

The global lens blocker systems market has been segmented based on type of instrument, and modality. In terms of type of instrument, the market has been segmented into manual lens blockers and automatic lens blockers. The automatic lens blockers segment accounted for the largest share of the global lens blocker systems market in 2015, owing to factors such as increasing technological advances in the automatic lens blockers and new market players entering the segment. Based on modality, the market has been segmented into standalone lens blockers and portable lens blockers.

Increasing prevalence of vision problems such as myopia and presbyopia among large population across the world, wide range of eyewear available in the market, rising population base of patients with uncorrected vision especially in the emerging countries, growing awareness among consumers worldwide regarding the importance of eye checkup, and increasing demand for better prescription lens products are factors driving the global lens blocker systems market. Expansion of the wearer base, rising number of eye disorders especially in the western countries, myopia boom in Asia Pacific, increasing disposable income of consumers, and rising number of players participating in the market and expansion of their product portfolio, and introduction of new and advanced products and technologies in the market are expected to drive the global lens blocker systems market during the forecast period. However, increasing preference for refractive surgeries, such as LASIK and other procedures, is expected to restrain the global lens blocker systems market.

In terms of region, the global lens blocker systems market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global lens blocker systems market in 2015 due to factors such as increasing demand for prescription lenses, rising pool of patients with vision problems, and adequate reimbursement. However, the market in Asia Pacific is expected to expand at the highest CAGR during the forecast period. According to World Health Organization statistics, Asia Pacific had an estimated 1 million blind children in 2012, out of which around 400,000 were from China. According to BBC News, there is an extraordinary rise in myopia among adults in the major countries in Asia. As compared to the U.K., where the average level of myopia is around 20% to 30% of the population, the prevalence in Asia Pacific has increased to 80% to 90% of the adult population suffering from the problem. These factors are expected to increase demand for prescription lenses in the region, and drive the lens blocker systems in Asia Pacific.

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20789

Major players in the global lens blocker systems market include NIDEK, Co., Ltd., Essilor International S.A., WECO Electrical Connectors, Inc., Huvitz Co. Ltd., Briot USA, Inc., Dia Optical, Co., and US Ophthalmic.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Pneumoperitoneum Needles Market Growth is Propelled by the Increase in Abdominal Disorders

Pneumoperitoneum needle, also known as Veress insufflation needle, is used in laparoscopic surgery to introduce gaseous fluids into peritoneal cavity to inflate the peritoneal cavity and create pneumoperitoneum. Laparoscopic and endoscopic surgery ae widely used in surgical procedures to treat number of disorders that were done by traditional surgical techniques. The pneumoperitoneum needle consist of a housing, a tubular body prolonging from a distal surface of housing, and a long, hollow tubular rod slidably inserted within the tubular body. The tubular body includes a passage for the administration of gas. The global pneumoperitoneum needle market is growing substantially driven by increasing abdominal disorders and their treatment involving laparoscopic surgery. In laparoscopic procedure, pneumoperitoneum gases are introduced into the peritoneal cavity (interior of abdomen) by creating a small incision to expand the peritoneal cavity, away from the peritoneum cavity wall and vital organs. Laparoscopic procedures are performed in general surgeries such as appendectomies, anti-reflux surgeries and hernia repair, cholecystectomies, urological surgeries such as prostatectomies and nephrectomies, gynecological surgeries, colorectal surgeries, bariatric surgeries such as sleeve gastrectomies, gastric banding, and gastric bypass. Constant advances in pneumoperitoneum needles and their significant role have made them an integral part of operational procedures.

Read More Information Regarding Pneumoperitoneum Needles Market: http://www.transparencymarketresearch.com/pneumoperitoneum-needles-market.html

The rise in the Pneumoperitoneum Needles Market with increasing laparoscopic surgery is attributed to the technological advances in the laparoscopic instruments. Key drivers of the global pneumoperitoneum needles market are advantages of minimal invasive laparoscopic surgeries such as reduced time spent at the hospital and quick recovery. Pneumoperitoneum needles are used in laparoscopic surgeries involving bariatric surgeries. Furthermore, increasing number of cholecystectomy surgeries performed globally are making significant contribution to the growth of the pneumoperitoneum needles market. Moreover, growing patient and physician preference for laparoscopic surgery as compared to open surgery, rise in geriatric population, and rise in prevalence of colorectal cancer are likely to boost the global pneumoperitoneum needles market.

High cost of laparoscopic minimally invasive surgeries is projected to hamper the growth of the market. Furthermore, lack of skilled professionals to perform these surgeries is expected to restrain the pneumoperitoneum needles market.

The pneumoperitoneum needles market can be segmented based on application, distribution channel, and region. In terms of application, the market can be segmented into gynecological surgery, urologic surgery, and general surgery. The gynecological surgery segment accounts for the major share of the market. This is attributed to widespread use of laparoscopic surgery in gynecology and obstetrics, particularly in procedures such as myomectomy, hysteroscopy, amnioscopy, fetoscopy, hysterectomy, and ovarian cyst removal. Based on distribution channel, the pneumoperitoneum needles market can be segmented into hospitals and ambulatory surgical centers. Geographically, the market can be segmented into five main regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the pneumoperitoneum needles market, followed by Europe, due to technological advancement, advanced clinical facilities, and large number of manufacturing companies in this region. Asia Pacific and Latin America are expected to witness strong growth, attributed to advancement in medical facilities, developing health care industry, rising awareness about laparoscopic surgeries, and increasing number of product launches in developing nations. Therefore, these regions present significant opportunities for manufacturers of pneumoperitoneum needles.

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20936

Key players in the pneumoperitoneum needles market are Medline Industries, Inc., Medtronic, Medax Srl, Ethicon US, LLC (Johnson & Johnson), Cooper Surgical, Inc., CONMED Corp., LaproSurge, Vectec S.A., WiSAP Medical Technology, and Maxer Medizintechnik GmbH, among others.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Tongue Depressors Market Growth is Supported by the Rising Number of Periodontal Diseases

A tongue depressor is a popular tool used in medical practice to depress the tongue which allows examination of cavity of mouth and throat (oropharynx). Typically, a tongue depressor is used by ear-nose-throat (ENT) specialists as a surgical instrument. Pediatricians, doctors, and physicians use a tongue depressor to check for possible infections, sores in the palate, throat, and teeth. This tool pushes the tongue back, so that experts can examine the conditions of tonsils and palate. They look for redness, swellings, and coating on the back of the throat to diagnose infection/disease. A tongue depressor is a simple device; however, it is quite useful for many diagnostic purposes.

Read More Information Regarding Tongue Depressors Market: http://www.transparencymarketresearch.com/tongue-depressors-market.html

Early detection of infection, sores, or other medical conditions can help in early diagnosis and treatment. Normally, tongue disposables are made up of wood. However, historically, tongue depressors have been made of a variety of materials. Earlier types of depressors were made from pine, redwood, and balsa. For example, tongue depressors used in the American Civil War made from wood and metal still exist. The tool is less than half an inch in width and it may be few inches in length. Generally, the size of the tongue depressor is kept standard. Tongue depressors are made of high quality material 6’ x 3/4" which has polished, smooth surfaces, and clean edges for greater patient comfort. The size may differ depending on usage and application. Tongue depressors are manufactured keeping following things in my mind splinter free, use for oral patient examination and patient care, individually wrapped & sterility, other uses in arts & crafts.

Drivers of the global tongue depressor market are rise in number of periodontal diseases, increase in geriatric population, rise in number of infections related to palate, teeth, and throat, growing health care expenditure, and rise in disposable income. Rise in cost of dental treatment, other surgical treatment related to periodontal, throat related infections, quality of the products are the major restraints of the market.

The global tongue depressors market can be segmented based on type of material, application, and region. In terms of type of material, the global tongue depressor market can be classified into wood, metal, plastic, and other. Tongue depressors made of wood have been used for years. However, plastic and metal tongue depressors are also widely used in surgical operations and dental treatments. Based on application, the global tongue depressors market can be classified into hospitals, private clinics, academic & research institutes, and others.

In terms of region, the global tongue depressors market can be segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to dominate the global tongue depressors market due rising prevalence of surgical operations, introduction of newer techniques, technological advancements in medical devices, and rise in health care expenditure. After North America, Europe is anticipated to dominate the global tongue depressors market due to growing number of periodontal and throat related infections and diseases, rise in geriatric population, and presence of key players in the market. Usage of low cost alternatives is likely to restrain the global tongue depressors market growth in the near future. Asia Pacific is expected to grow at fastest rate, due to rise in geriatric population, increase in disposable income, and government initiatives in health care.

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20942

Major players in the global tongue depressors market include Puritan Medical Products, Agaplastic, DTR Medical, Fazzini, F.L. Medical, FASA GROUP, Franz Mensch, Parburch Medical Developments, Plasti Lab, Shufa Dental, Timesco, US Ophthalmic, A. Algeo, and Asa Dental.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Rising Longevity of People to Create Growth Opportunities for Ileostomy Market

The global ileostomy market demonstrates a high degree of consolidation, finds a new research study by Transparency Market Research (TMR). Coloplast, Hollister, and Convatec are the leading players in this market, among which Coloplast held the dominant position in 2016 with a share of 36%. With a diverse product portfolio and a number of mergers, acquisitions, and strategic partnerships that took place recently, Coloplast is likely to continue leading the market over the next few years.

Read More Information Regarding Ileostomy Market: http://www.transparencymarketresearch.com/ileostomy-market.html

Other prominent players in this market are focusing aggressively on diversifying their product offerings, for which they are expected to increase research and development activities in the years to come, notes the research study.

According to the research report, the global market for ileostomy stood at US$765.2 mn in 2015. Proliferating at a CAGR of 8.90% over the period from 2016 to 2024, the market is anticipated to attain a value of US$1.65 bn by the end of the forecast period. The demand for stoma bags is much higher than other equipment and the trend is anticipated to remain so over the period of the forecast, states the report.

Demand for End Ileostomy to Remain High 

Based on procedure, the report bifurcate the global ileostomy market into end ileostomy and loop ileostomy. Among the two, the end ileostomy led the overall market in 2015 and is anticipated to remain at the leading position during the forecast period, thanks to its increasing application for the treatment of inflammatory bowel diseases, which is highly prevalent among global population.

Regionally, the report has classified the worldwide ileostomy market into Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa. With a share of 43.2%, Europe led the global market in 2015. With the presence of a well-developed healthcare infrastructure, supporting the expansion of this market in this regions, the Europe ileostomy market is likely to remain on the top over the next few years. Apart from this, the presence of leading companies here is also expected to aid this regional market in the near future, notes the study.

Rise in Geriatric Population to Boost Demand 

As per a TMR analyst, “the growth in the geriatric population will fuel the demand for ileostomy substantially in the near future, as people above 80 years are extremely vulnerable to a number of chronic diseases.” “The increase in longevity, globally, is likely to boost the demand for these procedures in the coming years, thus creating lucrative growth opportunities for the market,” he added further.

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23285

On the other hand, the augmenting demand for alternative procedures, although expensive but highly efficient, may inhibit the market’s growth trajectory over the forthcoming years. In addition to this, the lack of favorable reimbursement policies will remain the bottleneck for this market in the near future, states the report.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Government Initiatives to Prevent Food and Water-Borne Diseases Accentuate E. Coli Testing Market

Global E. Coli Testing Market: Snapshot 

E. coli (Escherichia coli) is a fecal coliform bacteria commonly found in intestines of humans and animals. Most of the E. coli strains are harmless, however certain strains are known to cause harmful medical complications. These include neonatal meningitis, gastrointestinal infections, cholecystitis, bacteremia, urinary tract infection (UTI), cholangitis, and pneumonia and mainly spreads through contaminated water or food. As this organism is found in intestinal tract of humans, it is considered as an indicator of fecal contamination. Hence, food and water samples are regularly tested for E. coli to avoid foodborne infections.

Read More Information Regarding E. Coli Testing Market: http://www.transparencymarketresearch.com/e-coli-testing-market.html

Sudden outbreak of drug resistant E. coli strains has raised serious health concerns. The epidemic has spread to various regions of the world including North America and parts of Europe. These factors have led governments and regulatory agencies to adopt preventive measures to avoid such epidemics. Hence Environment Protection Agencies (EPA) across the globe have laid strict guidelines for water testing. These guidelines are practiced by municipal water suppliers, bottled water suppliers, waste water treatment plants, and private well owners.

Spurred by these factors, the global E. coli testing market is expected to reach US$2.36 bn by the end of 2025, from US$1.18 bn in 2016. If these figures hold true, the global E. coli testing market will exhibit a CAGR of 8.0% between 2017 and 2025.

Home and Drinking Water Segment to Continue Exhibiting Highest Demand 

In terms of environmental testing methods, the global E. coli testing market is bifurcated into environmental testing method and clinical testing methods. The environmental testing method segment is further classified into membrane filtration (MF), multiple tube fermentation (MTF), and enzyme substrate method. Of these, holding majority share, the enzyme substrate method emerged dominant in the market in 2016. As the method is relatively more cost-effective and does not require skilled professionals for conducting it, is likely to retain its top slot through the forecast period.

Likewise, the clinical testing segment is classified into polymerase chain reaction (PCR), enzyme immunoassay (EIA) tests, and others. Of these, enzyme immunoassays testing will continue holding the largest share in the market through the forecast period.

By end user, the market can be categorized as waste water treatment organizations, bottled water suppliers, home and drinking water suppliers, and others. Of these, holding over 49.7% of the market, the home and drinking water segment emerged dominant in 2016. While the segment is expected to remain at the lead through the coming years, the market will also witness rising demand from waste water treatment organizations. Furthermore, the increasing drinking water crisis and frequent outbreak of water borne diseases will put pressure on governments to ensure high standards of home and drinking water, thus sealing the dominance of the segment.

North America to Remain Dominant Regional Market through Forecast Period 

Regionally, the global E. coli testing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In 2016, North America held the dominant share of nearly 44.5% in the global E. coli testing market. North America has been one of the early adopters of the latest technologies. Besides this, the region also boasts a sophisticated healthcare infrastructure, which is aiding the growth of the E. coli testing market.

Meanwhile, the Europe market is saturated and growing at slow rate while Asia Pacific is anticipated to witness the fastest CAGR during the forecast period with major contribution of countries such as India, Japan and China. New product launches, favorable regulations, ability of patients to pay for advanced technology products, and growing awareness are likely to drive the market in Asia Pacific during the forecast period.

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4822

Some of the key players operating in the E. coli testing market are IDEXX Laboratories, Inc., Meridian Bioscience, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., CPI International, Inc., Bio-Rad Laboratories, Inc., Pro-Lab Diagnostics, Inc., Alere Inc., BioMerieux Inc., and NanoLogix, Inc.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Surge in the Uptake of Expensive Treatments to Bolster Surgical Drainage Devices Market Growth

The intense rivalry between the leading players, Acelity L.P. Inc., Smith & Nephew Plc., and Cardinal Health, defines the competitive landscape of the global market for surgical drainage devices, finds a report by Transparency Market Research (TMR). These three manufacturers held nearly 74% of the overall market in 2015.

Read More Information Regarding Surgical Drainage Devices Market: http://www.transparencymarketresearch.com/surgical-drainage-devices-market.html

Hitherto, the key participants concentrated more on product innovation and advancements in technology. However, a shift in their focus towards mergers and acquisitions can be observed in the coming years. Analysts expect the increase in acquisitions to lead to market consolidation and result in heightened competition.

According to this research report, the overall opportunity in the global surgical drainage devices market was worth US$2.8 bn in 2015. Expanding at a 2.60% CAGR over the period from 2016 to 2024, the market is anticipated to touch US$3.5 bn by the end of the forecast period. The demand for active drainage devices is much higher than passive devices, thanks to the rising level of awareness among consumers pertaining to the benefits active devices offer, such as minimal tissue trauma, reduced risk of wound infection, and no excoriation of skin. The scenario is likely to remain so over the period of the forecast, states the market study.

Continued Dominance by North America in Global Surgical Drainage Devices Market

The report further presents a geographical analysis of the worldwide market for surgical drainage devices. As per the study, Asia Pacific, North America, Latin America, the Middle East and Africa, and Europe are the prime regional markets for surgical drainage devices across the world. With a share of nearly 40%, North America led the global market in 2016. Researchers anticipate that this regional market will remain dominant throughout the period of the forecast, thanks to the rising base of geriatric population, increasing incidence of cardiovascular disorders, and the escalating uptake of advanced treatment procedures.

Among other regional markets, Asia Pacific is expected to witness a high-paced growth over the forthcoming years, thanks to the presence of ample opportunities and untapped potential. The growing awareness among consumers and the rising prevalence of lifestyles diseases are likely to reflect positively on the demand for these devices in this region during the forecast period. The Middle East and Africa and Latin America and are also projected to experience a healthy growth rate in their respective markets for surgical drainage devices in the near future, reports the research study.

Increase in Surgical Procedures to Fuel Demand for Surgical Drainage Devices

The demand for surgical procedures has increased substantially across the world since the past few years. The main factors behind this are the increasing incidence of road accidences and sports injuries and the rising population of elderly people, who are prone to various types of chronic diseases and infections. According to a TMR analyst, “the rising adoption of surgical procedures, worldwide, is the key driving force behind the upswing in the demand for surgical drainage devices.”

Perceive the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21800

Another important factor behind the growth of the global surgical drainage devices market is the escalating uptake of expensive treatments, boosted by the increasing disposable income of consumers. In addition to this, the technological advancements and the growing usage of these devices are likely to stimulate this market significantly over the forecast period. However, the market may face issues from the lack of clinical knowledge and expertise among practitioners in the years to come, which may impact the market negatively over the years to come, notes the study.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Growth of Drug Discovery Channels in Emerging Regions Drives Tissue Diagnostics Market

Global Tissue Diagnostic Market: Snapshot

With the increased prevalence of cancer, the market for tissue diagnostics has a gained significant impetus across the world. The infrastructural development in the medical and healthcare industry is another important factor that has boosted the global tissue diagnostics market substantially over the past few years.

Perceive the Report Details for Tissue Diagnostic Market: http://www.transparencymarketresearch.com/tissue-diagnostics-market.html

Over the forthcoming years, the rising trend of the quantitative and qualitative analyses of tissue samples, discovery of target specific antibodies in the biopharmaceutical industry, and the growing awareness about tissue diagnosis in emerging economies are expected to act as the most prominent factors behind the growth of this market. Thanks to these factors, the market, which stood at US$3.57 bn in 2015, is estimated to expand at a 9.50% CAGR between 2016 and 2024 and touch a value of US$8.02 bn by the end of 2024.

Tissue Diagnostic Instruments to Continue Enjoying Strong Demand

The two main products available in the global tissue diagnostic market are instruments and kits. Among the two, instruments surfaced as the key contributor to this market in 2015, holding a share of more than 77%. With the high usage of tissue diagnostic instruments in labs, hospitals, and diagnostic centers for faster and accurate analysis, their demand is anticipated to increase remarkably over the next few years, maintaining the lead of this product segment. The continual advancements in these instruments, such as reduction in equipment size and increased functionality, coupled with reasonable pricing, are projected to add to the growth of this segment in the years to come.

Hospitals, research laboratories, ambulatory surgical centers (ASCs), and diagnostic centers are the prime end users of tissue diagnostic products and services. Hospitals, with a majority share, has acquired the position of the leading contributor to this market and is anticipated to retain this over the forthcoming years. The increasing prevalence of cancer, especially various forms of tissue sarcoma, rising healthcare expenditure in emerging as well as developed countries, and the expanding base of the geriatric population are expected to drive the demand for tissue diagnostic products and services in hospitals and other end users in the near future.

North America to Report Continued Dominance

The Middle East and Africa, Europe, North America, Latin America, and Asia Pacific have emerged as the predominant geographical segments of the worldwide tissue diagnostic market. With a share of around 40%, North America registered dominance over these in 2015, thanks to a well-established pharmaceutical and biotechnology industry and the increase in research activities. Analysts predict that this regional market will remain on the top over the next few years on the grounds of the surging research capital, introduction of improved and technologically advanced tissue diagnostic devices, and the presence of the leading market players in a large number.

In the recent times, the North America market for tissue diagnostics has been closely followed by Europe and Asia Pacific and the scenario is likely to remain more or less the same over the forthcoming years. The market for tissue diagnostics in Europe, which was primarily driven by the escalating investments from various research organizations for the advanced study of cancer, is likely to benefit further from the change in healthcare reforms, increasing implementation of government regulations, growth in the pharmaceutical industry, and the technological advancements in diagnostic technology. Asia Pacific, on the other hand, is expected to gain substantially in the years to come from ongoing industrialization and the continual drug discovery.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19607

Abbott Laboratories, Becton Dickinson & Co., Genomic Health Inc., 3DHISTECH, Danaher Corp., Thermo Fisher Scientific Inc., GE Healthcare, Cell Signaling Technologies, Agilent Technologies, and Roche Diagnostics are some of the key players in the global tissue diagnostic market.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Demand for At-Home Fetal Heart Monitors Drives Fetal Doppler Monitoring System Market

Fetal doppler monitor, commonly known as baby heartbeat monitor, is a handheld ultrasound transducer used to detect the fetal heartbeat for prenatal care. Fetal doppler monitor provides information about the fetus, which is similar to that of fetal stethoscope, and it acts as an indicator of stress. The stress usually occurs during birth and labor period, which can be detected using the ultrasound probe and electrocardiography. Over the counter sale and use of Doppler ultrasound heartbeat monitors are used for listening to the heartbeat of a fetus. These are legally marketed as prescription devices and should be used under supervision of health care professionals. Doptone is a type of handheld portable ultrasound tool used for fetal monitoring. The tool is beneficial due to its waterproof technology. However, fetal monitoring increases the risk of C-section due to high rate of technological uses, which can develop many complications for the fetus and the mother during pregnancy.

Perceive the Report Details for Fetal Doppler Monitoring System Market: http://www.transparencymarketresearch.com/fetal-doppler-monitoring-system-market.html

Increase in number of childbirth, awareness program for preventing the complications in childbirth, and demand for at-home fetal heart monitors are important driving factors of the global fetal doppler monitoring system market. In 2014, the U.S. Food and Drug Administration declared the usage of Doppler ultrasound heartbeat monitors and fetal ultrasound imaging should be by trained health care professionals, and they are not intended for over the counter sale or use. Cost of treatment or ultrasonography and sensitivity of child toward ultrasound devices are expected to hamper the fetal doppler monitoring system market growth.

The global market has been segmented based on monitoring process type, end-user, and geography. In terms of monitoring process type, the fetal doppler monitoring system market is classified into electronic fetal monitoring, external fetal monitoring, and internal fetal monitoring. In terms of end-user, the market for fetal doppler monitoring system is classified into diagnostic laboratories, hospitals, and research & development. In terms of geography, the market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Geographically, North America dominates the global market due to increase in advent of technology of ultrasound monitoring devices and growth in child development plan. Early-phase diagnosis and treatment of disease during pregnancy is driving the medical biotechnology market which in turn is expected to drive the fetal doppler monitoring system market in North America. Europe is the second leading market for fetal doppler monitoring system as there are favorable government policies regarding health care infrastructure and awareness of population development. The Asia Pacific market is expected to grow at a higher rate due to rise in population, changing lifestyle, rise in awareness between patients, and increase in per capita expenditure. In addition, economic growth is supporting the health care infrastructure improvement in developing countries such as India and China.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20951

The major players operating in the global fetal doppler monitoring system market include Medline Industries, Inc., Bionet Co., Ltd, Huntleigh Healthcare Limited, Promed Group Co., Ltd., ELCAT, Hadeco, Inc., Shenzhen Biocare Bio-Medical Equipment Co., Ltd., Advanced Instrumentations, and SonoScape Medical Corp.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Increase in Obese Population to Bolster the Growth of Transfemoral Compression Devices Market

Transfemoral compression devices have been in the market for quite a while. These devices are not regularly used due to high cost as compared to manual compression. The most common access site used for angiography is the femoral artery. After the procedure, the closure of site is usually done by manual compression. These devices have been used in practice to improve the efficiency and safety of such procedures. Increased efficacy in comparison with manual compression has been observed. The first method used for closing the holes in the femoral artery was the use of manual compression. As the holes got bigger, constraints on physicians increased due to rising complications. The increase in complication has resulted in technological innovation and led to the use of transfemoral approach.

Perceive the Report Details for Transfemoral Compression Devices Market: http://www.transparencymarketresearch.com/transfemoral-compression-devices-market.html

The transfemoral approach is commonly used to obtain arterial access during coronary angiography and amputation procedures. Hemostasis is usually performed through manual compression after removal of sheath. Vascular access site complications arise due to insignificant morbidity which occur after coronary interventional procedures. The percentage of these complications is about 0.5% to 16.8% of procedures performed. The rate of complications depend on the physician experience, the type of intervention applied, and introducer size.

Transfemoral products such as shrinkers are used for above the knee (AKA) and below the knee amputees (BKA). These products are available in wide variety of materials with different compression gradient. These transfemoral devices are prescribed by physician after two to three days of post operation. These devices help to reshape the limb after amputation procedure by increasing the blood flow and reducing the fluid retention in the surrounding area of the amputee’s limb. These transfemoral devices are generally used in hospitals, ambulatory surgical centers, and specialty clinics.

Increasing awareness and benefits related to transfemoral devices in terms of reduction in occurrence of complications and increased efficiency is expected to drive the transfemoral compression devices market during the forecast period. Transfemoral compression devices are the first choice in a number of cardiac catheterization labs across the world, as these provide increased comfort to patients.

Studies have shown that these transfemoral devices have reduced the procedure cost considerably when compared to the femoral compression devices in terms of procedure and hemostasis time and cost of repeating catheterization.

Major drivers of the transfemoral compression devices market are increase in obese population, rise in incidence of chronic diseases, growing awareness, increase in health care expenditure, and technological advancement. The total cost of device, stringent regulatory scenarios, and lack of skilled surgeons are the major restraints of the market. Increased risk of infection during the procedure is likely to hamper the growth of the transfemoral compression devices market during the forecast period. According to the American Academy of Orthopedic Surgeons, the number of arthroplasty surgeries to be conducted in the U.S. by 2030 will reach approximately to 3 million. Therefore, considering the rise in number of procedures in the U.S. alone, the incidence of orthopedic conditions globally shall also increase at a rapid pace creating opportunities in the transfemoral compression devices market.

Geographically, the global transfemoral compression devices market has been segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America leads the global transfemoral compression devices market largely because of increasing population, rising number of neurological surgeries, and technological advancements. North America was closely followed by Europe and Asia Pacific. Asia Pacific is an emerging market for transfemoral compression devices because of increasing health care expenditure in the region and rising demand.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20948

Key players in the global trans-femoral compression devices market are Abbot Laboratories, 3M Health Care, Paul Hartman AG, BSN medical, Merit Medical Systems, Inc., Vascular Perspectives Ltd., Terumo Corporation, Vascular Solutions, Inc., and TZ Medical, among others.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Increased Focus to Deliver Patient-centric Services will Boost Medical Device Technologies Market

Global Medical Device Technologies Market: Snapshot

The global medical device technologies market is largely steered by global players, of which a few that are involved in the manufacture of in vitro diagnostic devices hold the leading share. However, small players, predominantly from emerging economies, seeking entry into the market will alter the scenario in the coming years.

Perceive the Report Details for Medical Device Technologies Market: http://www.transparencymarketresearch.com/medical-device-technologies-market.html

The evolution of medical device technologies have led to breakthroughs in disease diagnosis and in treatment of diseases. Medical technologies have brought about efficacy, sustainability, and efficiency in healthcare systems with hi-tech devices such as ultrasounds, continuous glucose monitoring systems, and many more. These are some of the key growth drivers of the medical device technologies market.

On the flip side, serving as a hindrance to the market is rising incidence of use of non-licensed technology for the integration of biomedical devices.

A report by Transparency Market Research projects the global medical device technologies market to rise at a CAGR of 4.6% between 2017 and 2025 for the market to attain a value of US$563,886.5 mn by 2025 increasing from US$377,562.4 mn in 2016.

In Vitro Diagnostic Devices Dominate Device Type Segment due to Rising Incidence of Infectious Diseases

The global medical device technologies market has been studied in terms of device type, end-user, and region. The segments of the market depending upon device type are in vitro diagnostics devices, diagnostic imaging devices, cardiology devices, ophthalmology devices, orthopedic devices, endoscopy devices, diabetes care devices, wound management devices, anesthesia and respiratory care devices, kidney/dialysis devices, and other devices. The others segment comprises hospital supply devices, dental devices, and drug delivery systems.

In vitro devices and other devices led the global medical device technologies market in 2016 revenue-wise. The segment of in vitro diagnostic devices is expected to display notable growth in the coming years too because of rising incidence of infectious diseases along with the rising popularity of non-invasive diagnostic practices. The others devices segment is also expected to have a significant bearing on the development of medical device technologies market owing to the adoption of advanced technologies for the manufacture of devices such as dental implants.

On the basis of end-user, the market is classified into six segments, namely academics and research, hospitals, clinics, diagnostic centers, ambulatory surgical centers, and others. Hospitals and academics and research are presently the leading end-use segments of medical device technologies market. In 2016, hospitals held the leading share of the overall market owing to proliferation in the number of hospitals and government backing in many countries for improvement of the healthcare sector.

Demand for Technology-driven Patient Care Makes North America Leading Region

The key regional segments of the global medical device technologies market are North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. North America led the market in 2015 among other key regional segments because of rising incidence of cancer, metabolic diseases, and a large patient pool of individuals with chronic diseases and cardiovascular diseases that require crucial diagnosis and therapies. The demand for automated medical processes and the region being home to several manufacturers are also contributing immensely to the North America medical device technologies market.

Europe trailed North America in the global medical device technologies market in 2016 revenue-wise. In vitro diagnostic devices are majorly fuelling the growth of this regional market on account of high prevalence of cancer, stroke, and cardiovascular diseases.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11705

Some of the key players operating in the global medical device technologies market are Abbott Laboratories, Boston Scientific Corporation, Baxter International Inc., Medtronic plc, Cardinal Health Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Johnson & Johnson, Siemens Healthineers, Smith & Nephew plc, Stryker Corporation, and Koninklijke Philips N.V.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

X-ray Crystallography Market to Receive a Strong Impetus on the Back of Newer Applications

The global X-ray crystallography market is prognosticated to be popularized by the application of the technique for researching protein structures and assessing protein-ligand interactions, protein- nucleic acid complexes, viruses, and enzymes. Besides determining biological macromolecules and protein structure, X-ray crystallography could be used to reconstruct molecular crystalline structures. Commercially, the technique could be engaged to examine crystalline structures in jewels and artefacts, electronic chips, cosmetics, bones and teeth, and DNA and conduct pharmaceutical drug discovery.

Perceive the Report Details for X-ray Crystallography Market: http://www.transparencymarketresearch.com/xray-crystallography-market.html

2014 was declared as the International Year of Crystallography (IYCr2014) by United Nations Educational, Scientific, and Cultural Organization (UNESCO) for celebrating the significant role of the technique and promoting more discovery and research in the same field. With the course of time, the global X-ray crystallography market is prophesied to receive a strong impetus on the back of newer applications broadening the commercial employment of the technique. X-ray crystallography is swiftly becoming a precise and powerful technique for analyzing crystalline single structures.

Research organizations and academics associated with material and chemical sciences are foreseen to be key end users of X-ray crystallography. However, other prime end users of the technique could be manufacturing firms involved in demanding research and development activities conducted in the physical and atomic science domain. More opportunities for increasing the demand in the global X-ray crystallography market are forecasted to arise from the engagement of players in research and development activities performed in the fields of cosmetic, pharmacy, and biotechnology. The clinical application of examining atomic composition of crystalline structures in a human body could help the technique gain extensive recognition in hospitals and research laboratories.

X-ray crystallography is primarily utilized for determining arrangement of particles inside crystals. The diffraction of x-rays, after they are projected on a crystal, are measured by the crystallographer to determine the electron density of the crystal and also provides a three-dimensional image of the same. X-ray crystallography has been instrumental in determining types and lengths of chemical bonds and size of atoms among others. This is achieved primarily because crystal forms are available for semiconductors, metals, minerals, proteins and salts among others. An X-ray crystallography functions by projecting x-rays on a crystal held between the x-ray source and a screen. The diffracted rays are captured on the screen as dotted patterns. Fourier transformation mathematics is then applied for obtaining the shape of the crystal from the pattern obtained on the screen. X-ray crystallography is very important for synthesis of new drugs and medicines as it aids in determining the structure of their precursors.

Some of the major factors fuelling the demand for the global X-ray crystallography market is the increasing research and development being conducted for better drugs and medicines by the pharmaceutical industry. Factors such as development of multi-drug resistant bacteria, constantly evolving pathogenic viruses and quest for developing drugs for various types of cancer among others have been fuelling the demand for newer medicines. Such increase in demand for medicines has in turn fuelled the demand for x-ray crystallography since it aids in developing structure-based drug design for targeting specific bio-molecules among others. Additionally, x-ray crystallography is also been used for obtaining quantitative results of samples across industry verticals such as cement and wood among others. Such varied applications have also been positively impacting the growth of x-ray crystallography market. However, requirements for developing crystals, of the product to be studied, prior to utilizing x-ray crystallography have been a significant restraining factor. Also development of newer technologies such as x-ray free electron lasers can pose a threat for the x-ray crystallography market. The increasing research and development for advanced targeted drug delivery systems poses good opportunity for the global x-ray crystallography market.

By product type, the global x-ray crystallography market can be segmented into instruments, reagents and services.  Instruments segment is expected to remain the dominant segment during the forecast period. By applications, the x-ray crystallography market can be further segmented in to academic research, industrial, mineralogy & metallurgy, chemicals, pharmaceuticals and others. Pharmaceuticals segment is expected to remain the largest segment in 2023. By geography, the global x-ray crystallography market can be segmented into North America, Europe, Asia-Pacific (APAC) and rest of the world (RoW). North America can be expected to remain the leader in x-ray crystallography market globally, during the forecast period.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=9341

Some of the key companies leading the x-ray crystallography market globally are Thermo Fisher Scientific, Inc. (U.S.), Rigaku Corporation (Japan), Bruker Corporation (U.S.), Anton Paar GmbH (Austria), Danaher Corporation (U.S.), MiTeGen, LLC (U.S.), PerkinElmer, Inc. (U.S.), PANalytical B.V. [Spectris] (The Netherlands), Molecular Dimensions (U.K.), and Olympus Corporation (Japan) among others.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/